文献速递胰腺与胆道疾病

吸毒者氯胺酮相关性胆管病的磁共振胆管成像模式与临床特征

Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users.
PubMed 文献 · J Hepatol · 2018-03-16

本研究通过全港社区网络招募过去两年内每月至少使用两次、持续六个月以上的氯胺酮娱乐性使用者,行磁共振胆管成像(MRC)并由两名放射科医生独立判读,分析胆道异常与临床特征的关系。343名转介者中257人(74.9%)被纳入,159人(61.9%)MRC显示胆道异常;碱性磷酸酶(ALP)水平、无合并其他娱乐性药物使用及既往因泌尿系统症状急诊就诊对胆道异常有较高预测价值。戒断氯胺酮后胆管异常可逆,长期暴露后可能出现失代偿性肝硬化和死亡。

要点

  • 257名氯胺酮使用者中159人(61.9%)MRC显示胆道异常,表现为弥漫性肝外胆管扩张、梭形肝外胆管扩张及无肝外受累的肝内胆管改变。
  • ALP水平(OR 1.007;95%CI 1.002-1.102)、无合并娱乐性药物使用(OR 1.99;95%CI 1.11-3.58)及既往因泌尿系统症状急诊就诊(OR 1.95;95%CI 1.03-3.70)对MRC胆道异常有较高预测价值。
  • 单纯氯胺酮使用者中ALP预测胆道异常的AUC为0.800,最佳阈值≥113 U/L时阳性预测值为85.4%。

核心结论

  • 在大型氯胺酮使用者队列中识别出独特的MRC模式,ALP水平和无合并药物使用可预测胆道异常,戒断后异常可逆。
  • 研究结果可能有助于公共卫生应对日益增长的氯胺酮滥用问题。

研究设计与样本

  • 通过全港慈善机构社区网络招募过去两年内每月至少使用两次、持续六个月以上的中国氯胺酮娱乐性使用者。
  • 行磁共振胆管成像(MRC),由两名放射科医生独立判读,并将结果与临床特征关联分析。
  • 343名转介的氯胺酮使用者中257人(74.9%)被招募。

主要发现

  • 257名使用者的平均年龄为28.7(±5.8)岁,氯胺酮暴露时长为10.5(±3.7)年。
  • 159人(61.9%)MRC显示胆道异常,分类为弥漫性肝外胆管扩张(n=73)、梭形肝外胆管扩张(n=64)及无肝外受累的肝内胆管改变(n=22)。
  • 血清ALP水平(OR 1.007;95%CI 1.002-1.102)、无合并娱乐性药物使用(OR 1.99;95%CI 1.11-3.58)及既往因泌尿系统症状急诊就诊(OR 1.95;95%CI 1.03-3.70)对MRC胆道异常有较高预测价值。
  • 单纯氯胺酮使用者中ALP预测胆道异常的AUC为0.800,最佳水平≥113 U/L时阳性预测值为85.4%。
  • 戒断氯胺酮后胆管造影异常可逆,而长期暴露后可能出现失代偿性肝硬化和死亡。

关键数值与推荐

  • ALP水平与MRC胆道异常相关(OR 1.007;95%CI 1.002-1.102)。
  • 无合并娱乐性药物使用与MRC胆道异常相关(OR 1.99;95%CI 1.11-3.58)。
  • 既往因泌尿系统症状急诊就诊与MRC胆道异常相关(OR 1.95;95%CI 1.03-3.70)。
  • 单纯氯胺酮使用者中ALP预测胆道异常的AUC为0.800,最佳水平≥113 U/L时阳性预测值为85.4%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Recreational ketamine use has emerged as an important health and social issue worldwide. Although ketamine is associated with biliary tract damage, the clinical and radiological profiles of ketamine-related cholangiopathy have not been well described. METHODS: Chinese individuals who had used ketamine recreationally at least twice per month for six months in the previous two years via a territory-wide community network of charitable organizations tackling substance abuse were recruited. Magnetic resonance cholangiography (MRC) was performed, and the findings were interpreted independently by two radiologists, with the findings analysed in association with clinical characteristics. RESULTS: Among the 343 ketamine users referred, 257 (74.9%) were recruited. The mean age and ketamine exposure duration were 28.7 (±5.8) and 10.5 (±3.7) years, respectively. A total of 159 (61.9%) had biliary tract anomalies on MRC, categorized as diffuse extrahepatic dilatation (n = 73), fusiform extrahepatic dilatation (n = 64), and intrahepatic ductal changes (n = 22) with no extrahepatic involvement. Serum alkaline phosphatase (ALP) level (odds ratio [OR] 1.007; 95% CI 1.002-1.102), lack of concomitant recreational drug use (OR 1.99; 95% CI 1.11-3.58), and prior emergency attendance for urinary symptoms (OR 1.95; 95% CI 1.03-3.70) had high predictive values for biliary anomalies on MRC. Among sole ketamine users, ALP level had an AUC of 0.800 in predicting biliary anomalies, with an optimal level of ≥113 U/L having a positive predictive value of 85.4%. Cholangiographic anomalies were reversible after ketamine abstinence, whereas decompensated cirrhosis and death were possible after prolonged exposure. CONCLUSIONS: We have identified distinctive MRC patterns in a large cohort of ketamine users. ALP level and lack of concomitant drug use predicted biliary anomalies, which were reversible after abstinence. The study findings may aid public health efforts in combating the growing epidemic of ketamine abuse. LAY SUMMARY: Recreational inhalation of ketamine is currently an important substance abuse issue worldwide, and can result in anomalies of the biliary system as demonstrated by magnetic resonance imaging. Although prolonged exposure may lead to further clinical deterioration, such biliary system anomalies might be reversible after ketamine abstinence. Clinical trial number: NCT02165488.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Seto WK, Mak SK, Chiu K, et al. Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users. J Hepatol. 2018. PMID: 29551711. doi:10.1016/j.jhep.2018.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。